特发性肺纤维化网络战略：制定特发性肺纤维化治疗的综合方法。 - Suppr

Suppr

超能文献

The IPFnet Strategy: Creating a comprehensive approach in the treatment of idiopathic pulmonary fibrosis.

出版信息

Am J Respir Crit Care Med. 2010 Mar 15;181(6):527-8. doi: 10.1164/rccm.200903-0483ED.

DOI:10.1164/rccm.200903-0483ED

PMID:20208036

Abstract

摘要

相似文献

The IPFnet Strategy: Creating a comprehensive approach in the treatment of idiopathic pulmonary fibrosis.特发性肺纤维化网络战略：制定特发性肺纤维化治疗的综合方法。

Am J Respir Crit Care Med. 2010 Mar 15;181(6):527-8. doi: 10.1164/rccm.200903-0483ED.

The INPULSIS trials of idiopathic pulmonary fibrosis treatment: explaining further discrepancies on exacerbations.

Eur Respir J. 2016 Jan;47(1):344-5. doi: 10.1183/13993003.01274-2015.

Idiopathic pulmonary fibrosis and pirfenidone.特发性肺纤维化与吡非尼酮

Eur Respir J. 2010 Apr;35(4):728-9. doi: 10.1183/09031936.00006610.

Interferon gamma for idiopathic pulmonary fibrosis.用于特发性肺纤维化的干扰素γ

Lancet. 2009 Jul 18;374(9685):180-2. doi: 10.1016/S0140-6736(09)60689-9. Epub 2009 Jun 29.

[Two new drugs for the treatment of idiopathic lung fibrosis: A new therapeutic era!].[两种治疗特发性肺纤维化的新药：一个新的治疗时代！]

Rev Med Interne. 2015 Nov;36(11):719-21. doi: 10.1016/j.revmed.2015.05.011. Epub 2015 Jun 9.

Hot off the breath: A big step forward for idiopathic pulmonary fibrosis.呼吸新进展：特发性肺纤维化向前迈出一大步。

Thorax. 2014 Sep;69(9):791-2. doi: 10.1136/thoraxjnl-2014-205892. Epub 2014 Jul 4.

A new era of drug therapy for idiopathic pulmonary fibrosis.特发性肺纤维化药物治疗的新时代。

Lancet Respir Med. 2014 Dec;2(12):964-6. doi: 10.1016/S2213-2600(14)70257-7. Epub 2014 Nov 19.

Pirfenidone for idiopathic pulmonary fibrosis.吡非尼酮用于特发性肺纤维化

Lancet. 2011 May 21;377(9779):1727-9. doi: 10.1016/S0140-6736(11)60546-1. Epub 2011 May 13.

[randomized clinical trials of antifibrotic drug in idiopathic pulmonary fibrosis: an update].

Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):256-262. doi: 10.3760/cma.j.issn.1001-0939.2020.03.025.

Driving research and awareness of pulmonary fibrosis: Pulmonary Fibrosis Foundation is leading the path to a cure.推动肺纤维化研究及提高认知：肺纤维化基金会正引领治愈之路。

Am J Physiol Lung Cell Mol Physiol. 2020 Sep 1;319(3):L550-L553. doi: 10.1152/ajplung.00335.2020. Epub 2020 Aug 5.

引用本文的文献

NHLBI-CMREF Workshop Report on Pulmonary Vascular Disease Classification: JACC State-of-the-Art Review.美国国立卫生研究院心肺血液研究所 - CMREF 肺血管疾病分类研讨会报告：美国心脏病学会最新技术评论

J Am Coll Cardiol. 2021 Apr 27;77(16):2040-2052. doi: 10.1016/j.jacc.2021.02.056.

An American Thoracic Society Official Research Statement: Future Directions in Lung Fibrosis Research.美国胸科学会官方研究声明：肺纤维化研究的未来方向

Am J Respir Crit Care Med. 2016 Apr 1;193(7):792-800. doi: 10.1164/rccm.201602-0254ST.

ABCG2pos lung mesenchymal stem cells are a novel pericyte subpopulation that contributes to fibrotic remodeling.ABCG2阳性肺间充质干细胞是一种新型周细胞亚群，有助于纤维化重塑。

Am J Physiol Cell Physiol. 2014 Oct 15;307(8):C684-98. doi: 10.1152/ajpcell.00114.2014.

Effect and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis.霉酚酸酯治疗特发性肺纤维化的疗效和安全性。

Pulm Med. 2011;2011:849035. doi: 10.1155/2011/849035. Epub 2011 Nov 1.

Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal.特发性肺纤维化的干细胞治疗：方案建议。

J Transl Med. 2011 Oct 21;9:182. doi: 10.1186/1479-5876-9-182.

The pathology of bleomycin-induced fibrosis is associated with loss of resident lung mesenchymal stem cells that regulate effector T-cell proliferation.博来霉素诱导性纤维化的病理学与调节效应 T 细胞增殖的固有肺间充质干细胞的丧失有关。

Stem Cells. 2011 Apr;29(4):725-35. doi: 10.1002/stem.604.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验